Activating Compound | Comment | Organism | Structure |
---|---|---|---|
additional information | infection with Trypanosoma cruzi | Mus musculus |
Application | Comment | Organism |
---|---|---|
medicine | caspase-8 activity prevents type 2 cytokinine responses and is required for protective T cell-mediated immunity against Trypanosoma cruzi infection | Mus musculus |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
Cbz-IETD | - |
Mus musculus | |
viral FLIP | - |
Mus musculus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Mus musculus | O89110 | viral FLIP transgenic mice | - |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
spleen | - |
Mus musculus | - |
T-lymphocyte | - |
Mus musculus | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
IETD-4-nitroanilide + H2O | - |
Mus musculus | IETD + 4-nitroaniline | - |
? |
Synonyms | Comment | Organism |
---|---|---|
caspase-8 | - |
Mus musculus |